Philippe Goupille

Nerve ingrowth into diseased intervertebral disc in chronic back pain

TE Peacock, Philippe Goupille, JA Hoyland et al. · The Lancet · 1997 · 967 citations

Lumbosacral Radiculopathy, Degenerative Spine, Intervertebral Disc +10

Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

Florence Tubach, Dominique Salmon, Philippe Ravaud et al. · Arthritis & Rheumatism · 2009 · 628 citations · Full text

Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study

Xavier Chevalier, Philippe Goupille, A. D. Beaulieu et al. · Arthritis Care & Research · 2009 · 512 citations · Full text

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Peter Nash, Bruce Kirkham, Masato Okada et al. · The Lancet · 2017 · 390 citations · Full text

Rheumatoid Disorder, Rheumatology, Spirit-p2 Phase 3 +12

Prognostic factors for radiographic damage in early rheumatoid arthritis: A multiparameter prospective study

Bernard Combe, Maxime Dougados, Philippe Goupille et al. · Arthritis & Rheumatism · 2001 · 283 citations